Home Online Features Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline
Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline
Press Releases
Crown Laboratories, Inc., Revance Therapeutics, Inc.  
January 31, 2025

Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline

Crown offer of $3.65 per share is the only offer available to Revance stockholdersCrown offer unanimously approved by the Revance Board of DirectorsTeoxane withdraws its previous proposal, says it will

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social